Title:
NOVEL BRAF INHIBITORS AND USE THEREOF FOR TREATMENT OF CUTANEOUS REACTIONS
Document Type and Number:
WIPO Patent Application WO/2019/026065
Kind Code:
A3
Abstract:
The present invention discloses novel BRaf inhibitors, compositions comprising these inhibitors and uses thereof for the treatment, amelioration and/or prevention of cutaneous reactions.
Inventors:
SHELACH NOA (IL)
Application Number:
PCT/IL2018/050836
Publication Date:
August 01, 2019
Filing Date:
July 26, 2018
Export Citation:
Assignee:
LUTRIS PHARMA LTD (IL)
International Classes:
A61K31/52; A61P17/00
Foreign References:
| US20140005198A1 | 2014-01-02 | |||
| US20170100345A1 | 2017-04-13 | |||
| US20130226549A1 | 2013-08-29 |
Other References:
HATZIVAISSILIOU ET AL.: "RAF-inhibitors prime wild-type RAF to activate the MAPK pathway and Enhance Growth", NATURE, vol. 464, 2010, pages 431 - 436, XP055126892
Attorney, Agent or Firm:
KESTEN, Dov et al. (IL)
Download PDF: